Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon Apr 16, 2020 2:56pm
131 Views
Post# 30918035

RE:DIMI

RE:DIMIAs much as this article mentions a quote from Baxter who has an agreement with Spectral about distributing PMX (and EAA?) if and when it gets approved there is no mention of a Spectral product (SIMI or DIMI) on their website. They promote other dialysis systems so I think that to connect Baxter and Spectral's/Dialco products is a bit much but you could educate me!!!!
If you are refering to endotoxin referal then, great!
Bullboard Posts